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Abstract
Nitrated fatty acids (NFAs), endogenous products of nonenzymatic reactions of NO-derived
reactive nitrogen species with unsaturated fatty acids, exhibit substantial anti-inflammatory
activities. They are both reversible electrophiles and peroxisome proliferator-activated recep-
tor γ (PPARγ) agonists, but the physiological implications of their electrophilic activity are
poorly understood. We tested their effects on inflammatory and emphysema-related biomark-
ers in alveolar macrophages (AMs) of smoke-exposed mice. NFA (10-nitro-oleic acid or 12-
nitrolinoleic acid) treatment downregulated expression and activity of the inflammatory tran-
scription factor NF-κB while upregulating those of PPARγ. It also downregulated production of
inflammatory cytokines and chemokines and of the protease cathepsin S (Cat S), a keymedia-
tor of emphysematous septal destruction. Cat S downregulation was accompanied by
decreased AM elastolytic activity, a major mechanism of septal destruction. NFAs downregu-
lated both Cat S expression and activity in AMs of wild-typemice, but only inhibited its activity
in AMs of PPARγ knockout mice, pointing to a PPARγ-independent mechanism of enzyme
inhibition. We hypothesized that this mechanismwas electrophilic S-alkylation of target Cat S
cysteines, and found that NFAs bind directly to Cat S following treatment of intact AMs and, as
suggested by in silicomodeling and calculation of relevant parameters, elicit S-alkylation of
Cys25 when incubated with purified Cat S. These results demonstrate that NFAs’ electrophilic
activity, in addition to their role as PPARγ agonists, underlies their protective effects in chronic
obstructive pulmonary disease (COPD) and support their therapeutic potential in this disease.
Introduction
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the US
[1], characterized by chronic inflammation of small airways and destruction of alveolar septa
PLOSONE | DOI:10.1371/journal.pone.0153336 April 27, 2016 1 / 16
a11111
OPEN ACCESS
Citation: Reddy AT, Lakshmi SP, Muchumarri RR,
Reddy RC (2016) Nitrated Fatty Acids Reverse
Cigarette Smoke-Induced Alveolar Macrophage
Activation and Inhibit Protease Activity via
Electrophilic S-Alkylation. PLoS ONE 11(4):
e0153336. doi:10.1371/journal.pone.0153336
Editor: Yunchao Su, Augusta University, UNITED
STATES
Received: December 24, 2015
Accepted: March 28, 2016
Published: April 27, 2016
Copyright: This is an open access article, free of all
copyright, and may be freely reproduced, distributed,
transmitted, modified, built upon, or otherwise used
by anyone for any lawful purpose. The work is made
available under the Creative Commons CC0 public
domain dedication.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was supported by a Merit
Review award from the U.S. Department of Veterans
Affairs and National Institutes of Health grant
HL093196 to RCR. The funder had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
with consequent emphysema [2]. Such septal destruction reduces the surface area available for
pulmonary O2 and CO2 exchange, and combines with airway inflammation and mucus pro-
duction to impair respiratory mechanics. Because COPD is progressive and often fatal, and no
effective therapies are available to impede its course, identification of new potential therapeutic
targets is needed.
Among the many cell types that contribute to COPD pathophysiology, alveolar macro-
phages (AMs) are especially critical [3]. They are directly exposed to cigarette smoke, the
major risk factor for COPD, and other noxious airborne agents. Such agents activate AMs to
produce pro-inflammatory cytokines that activate other cells, and chemokines that attract neu-
trophils and T lymphocytes, prominent in COPD-associated inflammation. Such activated and
recruited cells likewise secrete mediators that further activate AMs in a vicious positive-feed-
back cycle. Yet AMs also exert an inflammation-dampening influence by phagocytosing apo-
ptotic neutrophils and epithelial cells that, if allowed to become necrotic, would further feed
the inflammatory cycle. Such phagocytotic activity of AMs is reduced in COPD, thereby exac-
erbating pathogenesis [4].
AMs are also the primary sources of elastin-degrading proteases that largely drive septal
destruction [5]. Most recent attention has focused on the Zn-containing matrix metalloprotei-
nases (MMPs), but cathepsins, including cathepsins K, L, and S, are also important mediators
of septal degradation [6]. Production of inflammation–associated oxidants by AMs can also
contribute to septal destruction.
Inflammation-associated oxidants include NO and derived reactive nitrogen species that
react nonenzymatically with unsaturated fatty acids to produce nitrated fatty acids (NFAs),
including 10-nitro-oleic acid (OA-NO2) and 12-nitrolinoleic acid (LNO2) [7], the most preva-
lent NO reaction products in the human bloodstream [8]. NFAs are potentially important
endogenous modulators of inflammatory processes [9–11], acting at least in part as agonists of
the nuclear hormone receptor peroxisome proliferator activated receptor-γ (PPARγ) [12].
They are also reversible electrophiles [13]. As such, they can react with thiol groups including
those of cysteine residues within proteins to produce an S-alkyl bond that is cleavable (thus
reversible) by reaction with free intracellular thiols such as glutathione (GSH). It has long been
observed that specific cysteines are preferentially alkylated, but the factors that render such spe-
cific cysteines more readily or stably alkylated are unknown. Known cysteine targets of NFA S-
alkylation include one within the ligand-binding site of PPARγ that contributes significantly to
agonist potency [14].
Reversible Cys S-alkylation provides a unique regulatory mechanism for biologically active
proteins. For example, reversible electrophiles regulate oxidative stress by reversibly S-alkylat-
ing the inhibitory protein Keap-1, allowing activation of the antioxidant transcription factor
Nrf2 [15]. NFAs may also alleviate inflammation by S-alkylating the pro-inflammatory tran-
scription factor NF-κB [10]. No such influence of reversible electrophiles in general or NFAs in
particular has been recognized in the pathophysiology of COPD. We hypothesized that anti-
inflammatory and related actions of NFAs may mitigate COPD pathogenesis, including secre-
tion of the proteases that mediate septal destruction, and tested this idea and the mechanisms
involved in AMs from smoke-exposed mice.
Materials and Methods
Animals
C57BL/6 and Tie2 Cre-PPARγflox/flox mice [16] were expanded from breeding pairs. Mice were
housed in microisolator cages under specific pathogen-free conditions and fed autoclaved
food. Male mice aged 6–8 weeks (20–25 g) were used in all experiments. All studies were
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performed according to protocols reviewed and approved by the VA Pittsburgh Healthcare
System Institutional Animal Care and Use Committee.
Smoke Exposure
Mice were exposed to cage-air cigarette smoke (CS) or to filtered air for 14 days. CS was gener-
ated by burning five 3RF4 research cigarettes (Tobacco Research Institute, University of Ken-
tucky, Lexington, KY) according to the Federal Trade Commission (FTC) protocol, each puff
being of 2-second duration and 35-ml volume, in an automated TE-10 smoking machine (Tea-
gue Enterprises, Davis, CA). The machine was adjusted to produce 89% sidestream and 11%
mainstream smoke. The chamber atmosphere was monitored to maintain TPM at 250 mg/m3.
Twenty-four hours following the last exposure, mice were euthanized and BAL fluid and lungs
were collected for further analysis.
BAL Fluid Collection, Cell Count and AM Isolation from Mice
BAL fluid was collected by flushing 3 × 1 ml of PBS containing 0.1 mM EDTA into the lung via
a tracheal cannula. The pooled BAL fluid was centrifuged at 500 × g at 4°C for 5 min. Pelleted
cells were then resuspended in 1 ml of PBS. Total cell number was counted by hemocytometer
and differential cell count was performed using cytospin preparations stained with Diff-Quik
(Siemens, Newark, DE). AMs were isolated as described previously [17].
Measurement of Cytokine, Chemokine and Cathepsin S Levels
Cell culture medium was collected and stored at –80°C. Levels of TNF-α and KC were mea-
sured using ELISA kits (R&D Systems, Minneapolis, MN) according to the manufacturer’s
instructions. Cat S levels in media samples were measured using an ELISA kit (MyBioSource,
Inc, San Diego, CA) according to the manufacturer’s instructions.
Western Blotting
Total protein extracts were prepared and Western blotting was performed as described previ-
ously [18]. Primary antibodies against NF-κB p65 (372), PPARγ (7196), lamin B1 (20682), bio-
tin (57636), Cat S (6505), and β-actin (1616) were from Santa Cruz Biotechnology (Santa Cruz,
CA). The secondary antibodies donkey anti-mouse IR-680RD (926–68072), donkey anti-rabbit
IR-680RD (925–68073), donkey anti-goat IR-680RD (926–68074), goat anti-rabbit IR-800CW
(925–32211), and goat anti-mouse IR-800CW (926–32210), were from LI-COR (Lincoln, NE).
The infrared signal was detected using an Odyssey Infrared Imager (LI-COR).
Immunoprecipitation
Total protein extracts were immunoprecipitated using the Dynabeads Protein G Immunopre-
cipitation kit (Invitrogen, Carlsbad, CA). Antibodies were bound to Dynabeads Protein G, and
the Dynabeads-Ab complex was used to precipitate target proteins from the total protein
extracts. Precipitates were washed to remove unbound proteins and complexes were eluted. All
samples were separated by electrophoresis on SDS-polyacrylamide gels, transferred to mem-
branes, and Western blotting was performed.
EMSA
Nuclear proteins (5 μg) were incubated with 2.5 nM infrared dye (IRDye) 700 end-labeled dou-
ble stranded consensus oligonucleotides for NF-κB or PPARγ (Table 1) in 10× binding buffer
(100 mM Tris, 500 mM KCl, 10 mMDTT; pH 7.5), poly dIdC (1 μg/μl in 10 mM Tris, 1 mM
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EDTA), 25 mMDTT and 2.5% Tween 20. Samples were then separated on 5% non-denaturing
polyacrylamide gels in 1× Tris-Borate EDTA buffer (130 mM Tris, pH 8.3, 45 mM boric acid,
2.5 mM EDTA). The infrared signal was detected using an Odyssey Infrared Imager (LI-COR).
Monocyte Chemotaxis Assay
Mouse blood monocytes were isolated using an EasySep mouse monocyte enrichment kit (Stem-
Cell Technologies Inc, Vancouver, BC, Canada). Briefly, leukocyte pools from blood were incu-
bated with an antibody mixture against non-monocytes followed by a biotin selection mixture
and magnetic particles. Labeled cells were removed using DynaMag-2 magnet (Invitrogen),
resulting in highly significant enrichment of monocytes in the remaining cell preparation.
Blind-well chemotaxis chambers separated with 8-mm pore polycarbonate membrane (Neuro
Probe Inc., Gaithersburg, MD) were used to assess migration of monocytes toward cell culture
media. The upper wells contained monocytes isolated as described above; the lower wells were
loaded with culture media supernatant frommacrophages isolated frommice exposed to ciga-
rette smoke for 14 days and then treated either with vehicle or with OA-NO2 for 6 h. The cham-
bers were incubated at 37°C for 1 h, after which the membranes were fixed and stained with Diff-
Quik stains. The membranes were retrieved and mounted on glass slides, covered with a cover-
slip, and examined under a microscope. The number of cells that migrated through the mem-
brane into the lower chamber and cells that were attached on the lower side of the membrane
were counted and transmigration was expressed as % of monocytes added in upper chamber.
Elastolytic Activity Assay
Intracellular and extracellular elastin degradation studies were performed using soluble and
insoluble fluorescein (FITC) labeled elastin respectively (Elastin Products Company, Inc,
Owensville, MO). To determine extracellular elastolytic activity insoluble FITC-elastin was
added to culture media or BAL fluid and treated as indicated. After incubation, insoluble elas-
tin was removed by centrifugation and fluorescence in supernatants was determined using
excitation at 490 nm and emission at 520 nm. Intracellular elastolytic activity was determined
by incubating AMs treated as indicated above with soluble FITC-elastin. After incubation cells
were washed and mounted with Vectashield mounting medium with DAPI (Vector Laborato-
ries, Burlingame, CA). The slides were viewed by an Olympus Fluoview FV1000 confocal
microscope (Olympus, Center Valley, PA) using a 60× objective lens along with Fluoview con-
focal software (FV10-ASW v1.7, Olympus).
ChIP Assay
The ChIP assay was performed using SimpleChIP Enzymatic Chromatin Immunoprecipitation
kit with magnetic beads (Cell Signaling Technology, Beverly, MA, USA). Briefly, cellular
Table 1. Consensus oligonucleotides employed.
Binding site Prime Sequence End labelling
κB Site F 50-AGTTGAGGGGACTTTCCCAGGC-30 IRDye 700
R 30-TCAACTCCCCTGAAAGGGTCCG-50 IRDye 700
PPRE Site F 50-AGACAAGTCAGAGGCCACGGT-30 IRDye 700
R 30-TCTGTTCAGTCTCCGGTGCCA-50 IRDye 700
Nonspeciﬁc Control F 50-AGACTGGGGCTGGAGTGCGGTT-30 IRDye 700
R 30-TCTGACCCCGACCTCACGCCAA-50 IRDye 700
doi:10.1371/journal.pone.0153336.t001
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chromatin was crosslinked with 1% formaldehyde for 10 min at room temperature, the cross-
linking was stopped with 0.125 M glycine, and cells were washed twice with ice cold PBS.
Nuclei were pelleted and digested by micrococcal nuclease. Following sonication and centrifu-
gation, equal amounts of sheared chromatin were incubated overnight at 4°C with antibodies,
IgG as negative control, or RNA polymerase II as positive control. Protein G magnetic beads
were then added and the chromatin was incubated with rotation for 2 h at 4°C. An aliquot of
chromatin that was not incubated with any antibody was used as the input control sample.
Antibody-bound protein/DNA complexes were eluted and subjected to real-time PCR as
described previously [18] with specific primers for Ctss (Cat S), CD36, and α-satellite
(Table 2).
Molecular Modeling and Computer Simulations of Binding of OA-NO2
with Cat S
Molecular modeling and covalent docking analysis was carried out as described previously
[19]. The X-ray structure of human Cat S {PDB ID 1NPZ; [20]} and its C25S mutant {PDB ID
1GLO; [21]} were obtained from the RCSB Protein Data Bank. Covalent docking was per-
formed with OA-NO2 (ligand) using Discovery Studio 2.5 (Accelrys Inc., San Diego, CA).
Cat S Enzyme Inhibition Assay
Cat S enzyme inhibition assay was performed using the Cathepsin S Drug Discovery Kit
(BML-AK431-0001; Enzo Life Sciences, Farmingdale, NY) according to the manufacturer’s
instructions.
Cat S Enzyme Activity Assay
Cat S enzyme activity in cell culture media samples was measured by incubating these samples
with Cat S-specific fluorescent substrate (Ac-KQKLR-AMC; 600742, Cayman Chemical)
according to the manufacturer’s instructions.
Cat S Cys Mutants
A plasmid containing the human Cat S gene was obtained from Addgene (#11251) and sub-
cloned into a pGEX 6P1 plasmid. Cysteine residues at positions 12, 25 and 110 or all three (12,
25 and 110) were mutated to serine using site directed mutagenesis (custom cloning core facil-
ity at Emory University, Atlanta, GA). Recombinant proteins were expressed in BL21-DE3
cells (Sigma-Aldrich, St. Louis, MO), purified using GST SpinTrap columns (GE Healthcare
Life Sciences), and the GST tag was removed with PreScission Protease (GE Healthcare Life
Sciences) according to the manufacturer’s instructions.
Table 2. Oligonucleotide primers employed.
Gene Primer Sequence Tm (°C) Amplicon Size (bp)
CD36 Promoter F 50-AATGCTTTATTCCTCCTTGTTTCC-30 62 96
R 50-TGCTAGAAAGGAAGTAGCTTCAG-30 62
Cat S Promoter F 50-GGCTCTTCTTGATGGCTTACT-30 62 77
R 50-AGCTAGTACAGTCACCTCTAGTC-30 62
α-satellite Cat #4486, Cell Signaling Technology
doi:10.1371/journal.pone.0153336.t002
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Cat S S-alkylation
To demonstrate S-alkylation of Cat S, human recombinant Cat S (EMDMillipore Billerica,
MA) and variants−Cat S WT, C12;25;110S mutant, C12S mutant, C25S mutant, and C110S
mutant−were incubated with test compounds for the indicated time periods and S-alkylation
was analyzed by running these samples in a SDS-PAGE gel under non-reducing conditions
and performing Western blots using antibody to biotin (Santa Cruz Biotechnology).
Electrospray Ionization-Liquid Chromatography-Mass Spectrometry/
Mass Spectrometry (ESI-LC-MS/MS)
ESI-LC-MS/MS analyses were performed on a Q Exactive Hybrid Quadrupole-Orbitrap mass
spectrometer (Thermo Scientific, Pittsburgh, PA). The electrospray system employed a 3.5 kV
spray voltage and a capillary temperature of 260°C.
Statistical Analysis
Data are presented as mean ± SD. Differences between groups were analyzed using an unpaired
t-test or analysis of variance, followed by Bonferroni multiple comparison correction. Analyses
were performed using GraphPad Prism 5.03 (GraphPad Software, La Jolla, CA). Differences
with P< 0.05 were considered significant.
Results
OA-NO2 reduces cigarette smoke-induced AM activation in mice
Considering the pivotal role of AMs in the response to smoke inhalation and COPD pathogen-
esis, we tested the effects of NFAs on AM activities relevant to inflammation and septal
destruction in a mouse model of COPD. We exposed mice to CS delivered via cage air for 14
days. Smoke exposure greatly increased the numbers of macrophages in BAL fluid, with lesser
increases in the number of neutrophils (Fig 1A and 1B). Because AMs represented the majority
of inflammatory cells found in BAL fluid of smoke-exposed mice, we assessed them further.
In vitroOA-NO2 treatment (no toxicity was observed, S1 Fig) of AMs isolated from BAL fluid
of smoke-exposed mice reduced both nuclear expression and DNA-binding activity of the pro-
inflammatory transcription factor NF-κB (Fig 1C and 1D), but increased those of the anti-
inflammatory nuclear hormone receptor PPARγ (Fig 1C and 1E). Based on these changes in
activity of pro- and anti-inflammatory transcriptional regulators, we predicted that expression of
pro-inflammatory genes would be reduced, and indeed found that secretion of TNF-α (Fig 1F)
and KC (Fig 1G) by AMs was suppressed. Secretion of chemokines was also reduced, as seen
using a monocyte transmigration assay (Fig 1H and 1I). Assessing emphysema-causing protease
secretion and elastin degradation, we found that OA-NO2 treatment markedly reduced secreted
Cat S levels and activity in culture medium (Fig 1J and 1K). Degradation of elastin by culture
medium of OA-NO2-treated AMs (Fig 1L) and intracellular elastin degradation by whole AMs
(Fig 1M) were similarly reduced. Thus, OA-NO2 suppressed both the inflammatory and proteo-
lytic activities induced by smoke exposure in AMs. As these cells play a prominent role in COPD
pathophysiology [3], these effects carry significant implications for modulation of this disease.
OA-NO2 Effects on Cathepsin S Expression, but not Activity, are
PPARγ-dependent
As NFAs are known to act both as reversible electrophiles and via PPARγ activation, we tested
which of these mechanisms was responsible for the observed reductions in Cat S expression
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and activity using AMs from wild-type (WT) and PPARγ knockout (KO) mice following
14-day in vivo smoke exposure and 6-h in vitro exposure to OA-NO2 or vehicle. Absence of
PPARγ in AMs from KOmice was confirmed by Western blotting, which also revealed modest
Fig 1. NFAsmitigate cigarette smoke-induced alveolar macrophage activation. (A, B) C57BL/6 mice were exposed to cigarette smoke (CS) or to
filtered-air for 14 days. Twenty-four h after the final exposure, BAL samples were collected. (A) Photomicrographs (40× objective lens) of Diff-Quik-stained
cells and (B) total (Tot), neutrophil (PMN), and macrophage (MAC) counts in BAL fluid from the indicated treatment groups. (C-M) Alveolar macrophages
(AMs) were isolated from BAL fluid of mice exposed to CS as described above and were then treated with 1 μMOA-NO2 or vehicle (Veh) for 6 h. (C) Western
blots for PPARγ and p65 in nuclear extracts. (D, E) DNA-binding activity of (D) NF-κB, and (E) PPARγ, in OA-NO2 or Veh treated AM extracts measured by
EMSA using IRDye oligonucleotides. (F, G) Release of (F) TNFα. and (G) KC. (H, I) Mouse monocytes were isolated and transmigration was assayed using
a chemotaxis chamber in which they were separated by an 8-mm pore polycarbonate membrane from chemoattractant culture media from the above
treatment groups. (H) Percentage transmigration, and (I) photomicrographs (40× objective lens) of the lower side of the polycarbonate membrane. (J) Cat S
expression and (K) activity in culture media from above treatment groups. (L, M) AMs were collected and treated as indicated above, then incubated with
FITC-elastin for further 1 h to determine (L) extracellular and (M) intracellular elastolytic activity (60× objective lens). Data are representative of two to three
independent experiments with cells obtained from n = 14–18 mice/group (cells from 3 mice pooled together). **P < 0.01, ***P < 0.001.
doi:10.1371/journal.pone.0153336.g001
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increases in Cat S (Fig 2A). OA-NO2 treatment reduced Cat S expression in AMs fromWT but
not PPARγ KOmice (Fig 2B), indicating that NFA-induced suppression of Cat S expression
requires PPARγ activation. In contrast, NFAs reduced Cat S activity in culture media of AMs
to approximately the same extent irrespective of the presence or absence of PPARγ (Fig 2C).
Therefore, inhibition of Cat S activity does not depend on PPARγ, and we thus hypothesized it
reflects S-alkylation by NFAs. Supporting this hypothesis, we found that NFA bound directly
to Cat S following incubation of Cat S with biotin-labeled OA-NO2, immunoprecipitation, and
Western blotting using anti-biotin antibody (Fig 2E). Conversely, supporting a PPARγ-depen-
dent mechanism of NFA effects on Cat S expression, we found by chromatin immunoprecipi-
tation (ChIP) that OA-NO2 treatment increased PPARγ binding to both the Cd36 promoter,
which is known to be upregulated by PPARγ activation, and also the Ctss (Cat S) promoter (Fig
2D). This was consistent with prior findings that under certain circumstances binding of
PPARγ to DNA inhibits rather than stimulates transcription [22]. Thus, the observed NFA
effects on Cat S expression and activity were mediated by distinct, complementary mechanisms
in which electrophilic addition plays a prominent role.
OA-NO2 Inhibits Cathepsin S by S-alkylating Cys25
We next sought to specifically identify the site of NFA-Cat S binding and the type of bond
involved. Molecular docking studies revealed covalent bond formation between the electro-
philic carbon of OA-NO2 and sulfur atom Cys25 of Cat S (Fig 3A). No covalent bond
Fig 2. NFAs’ inhibition of Cat S expression but not activity, is PPARγ-dependent. (A) Western blots for PPARγ and Cat S in whole cell extracts from
AMs isolated from BAL fluid of C57BL/6 (WT) and Tie2 Cre-PPARγflox/flox (KO) mice. (B, C) Mice were exposed to cigarette smoke (CS) for 14 days, AMs
were isolated and then treated with 0.5 and 1 μMOA-NO2 or Veh for 6 h. (B) Cat S expression and (C) activity in culture media. (D) Following AM isolation
and OA-NO2 (1 μM) treatment as above, chromatin was crosslinked and immunoprecipitated with PPARγ antibody; the antibody-bound DNA-protein
complexes were then subjected to real-time PCR with primers specific for PPRE sites in Cat S and CD36 promoter regions, α-satellite was used as control.
(E) As above, AMs were collected from CS-exposed mice and treated with 5 μM biotin-labeled OA-NO2 or Veh for 6 h. Total protein extracts were prepared,
Cat S was immunoprecipitated andWestern blotting was performed with anti-biotin and -Cat S antibodies. Data are representative of two to three
independent experiments with cells obtained from n = 14–18 mice/group (cells from 3 mice pooled together). *P < 0.05, **P < 0.01, ***P < 0.001, n.s. = non-
significant.
doi:10.1371/journal.pone.0153336.g002
NFAs Inhibit Emphysema-related Cathepsin via S-Alkylation
PLOS ONE | DOI:10.1371/journal.pone.0153336 April 27, 2016 8 / 16
Fig 3. NFAs inhibit Cat S enzymatic activity by S-alkylation. (A-C) Binding of OA-NO2 to Cat S was modeled in silico and evaluated in vitro. (A) Schematic
representation showing covalent interaction of OA-NO2 with Cat S Cys25 residue. (B) Schematic representation showing absence of any covalent interaction
of OA-NO2 with Cat S Cys25Ser mutation. (Left panels) Cat S is shown as a flat ribbon colored according to secondary structure; OA-NO2 (yellow) is shown
as a stick model and interacting amino acids are shown in scaled ball-and-stick representation. (Right panels) Cat S is shown with interacting amino acid
residues as a scaled ball-and-stick model with labels and OA-NO2 (yellow) as a stick model. In both figures the covalent bond is indicated bywhite arrow and
hydrogen bonds are indicated by green dotted lines. (C) Human recombinant Cat S in active form (200 ng) was incubated for 30 min with the indicated
compounds. Following incubation, S-alkylation of Cat S by biotin-labeled OA-NO2 in test samples was assessed byWestern blotting under non-reducing
conditions. (D) Human recombinant Cat S in active form (6 μU/μl) was incubated for 1 h with the indicated compounds and enzyme activity determined by
cleavage of fluorescent substrate peptide. Data are representative of three independent experiments with n = 4/group. *P < 0.5, ***P < 0.001.
doi:10.1371/journal.pone.0153336.g003
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formation was seen when Cat S with Cys25 to Ser mutated was used, as the oxygen in serine is
not sufficiently nucleophilic to bond with the NFA’s electrophilic carbon (Fig 3B).
We confirmed that NFA binds to Cat S protein by incubating recombinant human Cat S in
vitro with biotin-labeled OA-NO2 followed by Western blotting (Fig 3C). Incubation with
either OA-NO2 or LNO2 dose-dependently inhibited human Cat S activity, and at the highest
dose tested exhibited inhibition similar to that seen with the classic Cat S inhibitor E-64 (Fig
3D). This inhibition was blocked by the thiol exchange inhibitor bacitracin, thus confirming S-
alkylation as the mechanism of inhibition.
We next sought to specifically identify the site of NFA-Cat S binding and the type of bond
involved. We modeled Cat S in silico (Fig 4) to 1) determine the presence or absence of disul-
fide bonding for each Cys residue and the S atom’s partial positive charge (Fig 4A); and 2) cal-
culate solvent accessibility (Fig 4B), H-bonding potential (Fig 4C), and pKa (Fig 4D) for each
of its cysteine residues. The results suggested that Cys25 is the most nucleophilic and thus the
most likely site of S-alkylation. This conclusion was supported by in silicomodeling of
OA-NO2 bonded to Cys25, indicating appropriate solvent accessibility and the presence of sta-
bilizing H-bonds (Fig 4B–4D).
To test whether Cys25 was the specific Cat S residue to which NFAs bond covalently, we
incubated biotin-labeled OA-NO2 with WT Cat S or Cat S with Cys residues mutated to Ser
[either individually at Cys12 (C12S), Cys25 (C25S), or Cys110 (C110S), or at all three positions,
(C12;25;110S)]. OA-NO2 binding was then determined by Western blotting (Fig 5). OA-NO2
was bound to Cat S by S-alkylation only in Cat S WT, C12S, and C110S mutants; the interac-
tion was absent when Cys25 was mutated to Ser (C12;25;110S and C25S). These results indicate
that the S-alkylation of Cat S by OA-NO2 occurs specifically at Cys25.
To further confirm the covalent interaction we incubated OA-NO2 (or vehicle) with a syn-
thetic Cat S peptide (Cat S23-29) containing either the native Cys25 (sequence GACWAFS) or
a Cys25Ser substitution (GASWAFS), and analyzed the products by mass spectrometry, which
indicated that NFA was S-alkylated to the Cys25-containing fragment (Fig 6B and table). As
predicted, Cys25Ser mutation abolished NFA S-alkylation (Fig 6D and table) and no addition
was seen in the absence of NFA (Fig 6A and 6C and table). Our initial prediction, based on the
theoretical calculations shown in Fig 4, that Cys25 would be the alkylated residue was thus
confirmed.
Discussion
We find that NFA treatment of activated AMs from CS-exposed mice downregulates expres-
sion and activity of Cat S, a protease heavily involved in the septal destruction that leads to
emphysema. Because NFAs are known PPARγ agonists [23], we tested whether PPARγmedi-
ates their suppressive effects on Cat S, finding that NFAs downregulate both Cat S gene expres-
sion and its enzymatic activity. These actions are mechanistically distinct, however, as PPARγ
deletion eliminated NFA-induced downregulation of Cat S expression but not NFA-induced
inhibition of Cat S enzymatic activity. Further studies demonstrated that NFAs inhibit Cat S
activity via electrophilic S-alkylation. As our data show, this reversible addition of an NFA to
the Cat S protein is not random, but is directed toward a specific catalytic cysteine (Cys25) that
exhibits appropriate nucleophilicity, solvent accessibility, and potential of surrounding amino
acids for formation of stabilizing H-bonds. Thus, we found that NFAs act through distinct
PPARγ-dependent and -independent mechanisms that nonetheless act in a dual, functionally
concerted manner to reduce Cat S levels, leading to the observed decrease in AMs’ extracellular
and intracellular elastolytic activity. Such a reduction in vivo would be expected to alleviate
COPD severity and progression toward emphysema.
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Bonnaci and colleagues similarly observed PPARγ-dependent decreases in expression of
MMPs, another class of COPD-related proteases, in conjunction with PPARγ-independent
effects on enzyme activity [24]. Mechanisms of the apparent MMP inhibition were not investi-
gated, however. Reversible electrophiles, including NFAs, were found earlier to S-alkylate other
regulatory proteins, including the p65 subunit of NF-κB [10], protein kinase CB [25] and
Keap-1[15, 26], but these actions have not previously been linked to mechanisms of disease
Fig 4. In silicomodeling shows Cat S Cys25 is the preferred target for NFA S-alkylation. In silicomodeling of Cat S showing potential for electrophilic S-
alkylation. (A) Cysteine residues are indicated by yellow spheres and disulfide bonds by short yellow lines. Each residue is colored according to its calculated
pKa. The protein surface is colored to indicate solvent accessibility and the surface of the potential OA-NO2 binding pocket is colored according to its H-
bonding potential. The bar scales indicate the values corresponding to each color used. Numerical values of these parameters are shown in the
accompanying table. (B-D) In silicomodels of Cat S with OA-NO2 bound to Cys25. Protein surface is color coded to indicate: (B) solvent accessible surface
area (SASA); (C) potential for H-bond formation; (D) pKa of OA-NO2–Cat S binding pocket. OA-NO2 is rendered as a scaled ball-and-stick model and Cat S
as a stick model. The covalent bond between OA-NO2 and Cys25 is indicated by a red arrow.
doi:10.1371/journal.pone.0153336.g004
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pathogenesis. Indeed, despite NFAs’ recognized ability to electrophilically alkylate targeted
protein cysteines via Michael addition, the physiological and pathogenetic relevance of these
actions has remained largely unknown prior to our current investigations.
The biological roles of endogenous NFAs are likewise uncertain, but available evidence sug-
gests that they may be important inflammatory modulators. They are produced by nonenzy-
matic reaction of unsaturated fatty acids with NO-derived reactive nitrogen species [7],
production of which is upregulated during inflammation. Inflammation also upregulates cho-
lesteryl hydrolase activity [27], which drives release of free, active NFAs from their esters. Even
in the absence of inflammation, the combined concentrations of free and esterified fractions of
NFAs in blood are within the range required to activate PPARγ [8]. Endogenous NFAs may
also downregulate inflammation by S-alkylating NF-κB, and may alleviate inflammation-pro-
duced oxidative stress by S-alkylating Keap-1 [26]. Definitive proof of NFAs’ endogenous role
has remained elusive, however, because traditional techniques are not applicable: Endogenous
NFA production cannot be effectively blocked and their multiple mechanisms of action, as
illustrated by our present results, render it difficult to block their effects. Indeed, it will be chal-
lenging to block S-alkylation experimentally in intact cells.
Beyond Cat S regulation, we found that NFAs downregulate activation of AMs obtained
from smoke-exposed mice, as assessed by a variety of inflammatory markers including NF-κB
activity, cytokine/chemokine production, and transmigration. AMs are pivotal contributors to
inflammation, particularly in COPD [3]. Through their production of inflammatory cytokines
and chemokines [28], activated AMs serve to activate and recruit other cells, complementing
their own direct pro-inflammatory actions. Our finding that treating AMs with OA-NO2
reduces ability of their conditioned medium to recruit additional macrophages reveals a poten-
tially powerful pathway via which NFAs can act to alleviate inflammation. As key sources of
the principal elastolytic proteases, MMPs and cathepsins [5], AMs also contribute crucially to
emphysema-causing septal destruction. Thus, our finding that NFAs downregulate total Cat S
activity via both PPARγ- and electrophile-dependent mechanisms, while others found NFAs
downregulate MMP expression [24], points to a potentially important protective role of endog-
enous or therapeutically-aimed NFAs in COPD (Fig 7).
In summary, our findings demonstrate that NFAs act as both electrophiles and PPARγ ago-
nists to suppress the pathophysiology of CS-induced COPD. In particular, NFAs downregulate
expression of the septum-destroying protease Cat S while specifically S-alkylating the enzyme’s
Fig 5. NFAs S-alkylate Cat S specifically at Cys 25.Human recombinant Cat SWT and Cys mutants
C12;25;110S, C12S, C25S, C110S (200 ng) were incubated for 30 min with biotin-labeled OA-NO2 (1 μM).
Following incubation, S-alkylation of Cat S by biotin-labeled OA-NO2 was assessed byWestern blotting
under non-reducing conditions. Data are representative of two independent experiments.
doi:10.1371/journal.pone.0153336.g005
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Fig 6. Mass spectrometric analysis of Cat S Cys25 S-alkylation.One μg of synthetic Cat S23-29
containing either native Cys25 (GACWAFS) or Ser25 (GASWAFS) was incubated in vitro for 30 min with (A,
C) Veh or (B, D) 20 μMOA-NO2. Reaction mixtures were resolved by reverse phase chromatography and
analyzed by electrospray ionization-tandemmass spectrometry. (A, B) The spectrum for peptide GACWAFS
shows B, S-alkylation of OA-NO2 on the Cys residue but A, no alkylation by Veh. (C, D) Absence of S-
alkylation of OA-NO2 with peptide GASWAFSwhere Cys is replaced by a Ser residue. Table showsm/z of
fragment ions from peptide GACWAFS, with detected ions highlighted in color. Column AA identifies the
corresponding amino acids. Data are representative of three independent experiments.
doi:10.1371/journal.pone.0153336.g006
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catalytic Cys25, thus inhibiting its elastolytic activity and ability to promote emphysema. These
results provide mechanistic insights into the part NFAs may play in modulating COPD sever-
ity, highlighting the novel role of their electrophilic activity, and support their potential thera-
peutic role in this disease.
Supporting Information
S1 Fig. OA-NO2 treatment has no toxic effects on mouse AMs. AMs were isolated and cul-
tured as described and were treated with OA-NO2 (0.1, 0.5, 1, 5 and 10 μM) for 6 h. After treat-
ment AM viability, cytotoxicity and apoptosis were assayed as indicated inMaterials and
Methods. Data are representative of two independent experiments with n = 3/group.
(TIFF)
S1 File. Materials and Methods. Viability, Cytotoxicity and Apoptosis.Mouse AMs were
isolated and treated as indicated with OA-NO2. Cell viability, cytotoxicity and apoptosis were
measured according to manufacturer’s instructions using ApoTox-Glo Triplex Assay (Pro-
mega, Madison, WI). Briefly, at the end of the OA-NO2 treatment period 20 μl of viability/
cytotoxicity reagent containing both GF-AFC substrate and bis-AAF-R110 substrate was
Fig 7. Schematic illustration of effects of S-alkylation by NFAs on COPD. Exposure to cigarette smoke
induces COPDwith accompanying increases in inflammation (NF-κB), oxidative stress, and release of
elastolytic proteases (cathepsins and MMPs). Treatment with NFAs, acting partially through electrophilic S-
alkylation of specific cysteines, reverses all these COPD-associated changes.
doi:10.1371/journal.pone.0153336.g007
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added to all wells, briefly mixed by shaking, and incubated for 30 min at room temperature.
Viability and cytotoxicity were assessed by fluorescence measured using a plate reader (VIC-
TOR X, PerkinElmer; Waltham, MA). After measurement, 100 μl of Caspase-Glo 3/7 reagent
was added to each well, briefly mixed by shaking, and incubated for 30 min at room tempera-
ture. Apoptosis was assessed by luminescence measured using a plate reader.
(DOCX)
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